NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00934154,Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma,https://clinicaltrials.gov/study/NCT00934154,,COMPLETED,"This is a multi-centre Phase III randomized controlled study of patients with multiple myeloma (MM). Eligible patients who are not candidates for transplantation will be randomized to receive eight courses of Melphalan/Prednisolone with or without Thalidomide treatment. Thalidomide will be initiated at the dose of 100 mg/day and maintained at 100 mg/day. The patients will be assessed for any responses at the end of 2nd, 4th, 6th and 8th cycles of treatment. The toxicities will be assessed at monthly intervals. Patients will be assessed for the:

1. Incidence and grade of any toxicity
2. Level of maximum disease response
3. Time to disease progression
4. Time to death",NO,Multiple Myeloma,DRUG: Thalidomide|DRUG: Melphalan+Prednisolone,"response rate, 12 months","time to relapse, 18 months|overall survival, unlimited",,Cigdem Sahinbas YILMAZ,Turkish Society of Hematology Myeloma Study Group,ALL,"ADULT, OLDER_ADULT",PHASE3,122,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,TMSG-2005-001,2006-03,2009-09,2012-09,2009-07-08,,2013-08-15,"Baskent University School of Medicine Education and Research Hospital, Hematology Department, Adana, Turkey|Ankara Numune Education and Research Hospital,Hematology Department, Ankara, Turkey|Ankara University School of Medicine, Hematology Department, Ankara, Turkey|Gazi University School of Medicine, Hematology Department, Ankara, Turkey|Hacettepe University School of Medicine, Hematology Department, Ankara, Turkey|Akdeniz University School of Medicine , Hematology Department, Antalya, 07070, Turkey|Uludag University School of Medicine, Hematology Department, Bursa, Turkey|Osmangazi University School of Medicine , Hematology Department, Eskisehir, Turkey|Marmara University School of Medicine, Hematology Department, Istanbul, Turkey",
